Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVAC/LuCa with Chemotherapy in Stage IV NSCLC
NCT02669719Phase 2Unknown
- Sponsor
- Shanghai Chest Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2017
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DCVAC/LuCa in non-small cell lung cancer (NSCLC), sponsored by Shanghai Chest Hospital. Status: unknown.
02
Drugs
DCVAC/LuCa
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02669719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669719.